This editorial discusses the utility of home blood pressure monitoring for detecting white-coat and masked hypertension, introducing the Finn-Home outcome study in the Finnish general population.
Does home blood pressure monitoring predict cardiovascular outcomes in the general population?
This editorial highlights the growing evidence and guideline support for home blood pressure monitoring as an accessible and effective tool for detecting white-coat and masked hypertension and predicting cardiovascular outcomes.
T he common phenomena of white-coat and masked hypertension have established the need for assessing blood pressure (BP) out of the office, particularly using 24-hour ambulatory monitoring (ABPM). In the last 2 decades, evidence on the usefulness of the alternative method for out-of-office BP assessment, namely home BP monitoring (HBPM), has accumulated, and guidelines on using this method have recently been published in the United States and Europe. As with ABPM, HBPM allows the detection of white-coat and masked hypertension and has additional advantages, such as wide availability, low cost, and excellent acceptability by hypertensive patients for repeated use. n this issue of Hypertension, Niiranen et al present the results of Finn-Home, an outcome study of HBPM in the general population in Finland.
Stergiou et al. (Tue,) conducted a editorial in Hypertension. Home blood pressure monitoring (HBPM) was evaluated. This editorial discusses the utility of home blood pressure monitoring for detecting white-coat and masked hypertension, introducing the Finn-Home outcome study in the Finnish general population.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: